Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 304

The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.

Patients with COVID-19: in the dark-NETs of neutrophils

Open access
Ackermann, Maximilian, Anders, Hans-Joachim, Bilyy, Rostyslav, Bowlin, Gary L., Daniel, Christoph, De Lorenzo, Rebecca, Egeblad, Mikala, Henneck, Timo, Hidalgo, Andrés, Hoffmann, Markus, Hohberger, Bettina, Kanthi, Yogendra, Kaplan, Mariana J., Knight, Jason S., Knopf, Jasmin, Kolaczkowska, Elzbieta, Kubes, Paul, Leppkes, Moritz, Mahajan, Aparna, Manfredi, Angelo A., Maueröder, Christian, Maugeri, Norma, Mitroulis, Ioannis, Muñoz, Luis E., Narasaraju, Teluguakula, Naschberger, Elisabeth, Neeli, Indira, Ng, Lai Guan, Radic, Marko Z., Ritis, Konstantinos, Rovere-Querini, Patrizia, Schapher, Mirco, Schauer, Christine, Simon, Hans-Uwe, Singh, Jeeshan, Skendros, Panagiotis, Stark, Konstantin, Stürzl, Michael, van der Vlag, Johan, Vandenabeele, Peter, Vitkov, Ljubomir, von Köckritz-Blickwede, Maren, Yanginlar, Cansu, Yousefi, Shida, Zarbock, Alexander, Schett, Georg, Herrmann, Martin·2021·Cell Death & Differentiation

Abstract

SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs, occasionally causing death. Until effective vaccines are developed to curb the pandemic, it is paramount to define the mechanisms and develop protective therapies to prevent organ dysfunction in patients with COVID-19. Individuals that develop severe manifestations have signs of dysregulated innate and adaptive immune responses. Emerging evidence implicates neutrophils and the disbalance between neutrophil extracellular trap (NET) formation and degradation plays a central role in the pathophysiology of inflammation, coagulopathy, organ damage, and immunothrombosis that characterize severe cases of COVID-19. Here, we discuss the evidence supporting a role for NETs in COVID-19 manifestations and present putative mechanisms, by which NETs promote tissue injury and immunothrombosis. We present therapeutic strategies, which have been successful in the treatment of immunο-inflammatory disorders and which target dysregulated NET formation or degradation, as potential approaches that may benefit patients with severe COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41418-021-00805-z

Cites

184 of 184 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 184 references

Cited by

See all 304

Metadata

Authors
Ackermann, M., Anders, H.-J., Bilyy, R., Bowlin, G. L., Daniel, C., De Lorenzo, R., Egeblad, M., Henneck, T., Hidalgo, A., Hoffmann, M., Hohberger, B., Kanthi, Y., Kaplan, M. J., Knight, J. S., Knopf, J., Kolaczkowska, E., Kubes, P., Leppkes, M., Mahajan, A., Manfredi, A. A., Maueröder, C., Maugeri, N., Mitroulis, I., Muñoz, L. E., Narasaraju, T., Naschberger, E., Neeli, I., Ng, L. G., Radic, M. Z., Ritis, K., Rovere-Querini, P., Schapher, M., Schauer, C., Simon, H.-U., Singh, J., Skendros, P., Stark, K., Stürzl, M., van der Vlag, J., Vandenabeele, P., Vitkov, L., von Köckritz-Blickwede, M., Yanginlar, C., Yousefi, S., Zarbock, A., Schett, G., & Herrmann, M.
Venue
Cell Death & Differentiation
Published
2021-05-24
Volume
28
Issue
11
Pages
3125-3139
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W3164161224
Cited by
304
References
184
FWCI
17.40
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patients with COVID-19: in the dark-NETs of neutrophils. https://app.cochat.ai/papers/10.1038/s41418-021-00805-z
The paper
Ackermann, M., Anders, H.-J., Bilyy, R., Bowlin, G. L., Daniel, C., De Lorenzo, R., Egeblad, M., Henneck, T., Hidalgo, A., Hoffmann, M., Hohberger, B., Kanthi, Y., Kaplan, M. J., Knight, J. S., Knopf, J., Kolaczkowska, E., Kubes, P., Leppkes, M., Mahajan, A., . . . Herrmann, M. (2021). Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death & Differentiation. https://doi.org/10.1038/s41418-021-00805-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.